nodes	percent_of_prediction	percent_of_DWPC	metapath
Trabectedin—Alkylating Activity—Melphalan—peripheral nervous system neoplasm	0.433	0.556	CiPCiCtD
Trabectedin—Alkylating Activity—Dacarbazine—peripheral nervous system neoplasm	0.346	0.444	CiPCiCtD
Trabectedin—CYP2E1—Dacarbazine—peripheral nervous system neoplasm	0.0253	0.233	CbGbCtD
Trabectedin—PTGS1—Etoposide—peripheral nervous system neoplasm	0.016	0.148	CbGbCtD
Trabectedin—CYP2C9—Tretinoin—peripheral nervous system neoplasm	0.0154	0.141	CbGbCtD
Trabectedin—CYP2E1—Etoposide—peripheral nervous system neoplasm	0.0124	0.114	CbGbCtD
Trabectedin—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.0096	0.0884	CbGbCtD
Trabectedin—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.00893	0.0821	CbGbCtD
Trabectedin—CYP2C9—Cisplatin—peripheral nervous system neoplasm	0.00658	0.0605	CbGbCtD
Trabectedin—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.0041	0.0377	CbGbCtD
Trabectedin—CYP2D6—Doxorubicin—peripheral nervous system neoplasm	0.00403	0.0371	CbGbCtD
Trabectedin—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.00376	0.0346	CbGbCtD
Trabectedin—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.00256	0.0236	CbGbCtD
Trabectedin—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	7.82e-05	0.000892	CcSEcCtD
Trabectedin—Hypotension—Vincristine—peripheral nervous system neoplasm	7.8e-05	0.00089	CcSEcCtD
Trabectedin—Paraesthesia—Alitretinoin—peripheral nervous system neoplasm	7.77e-05	0.000888	CcSEcCtD
Trabectedin—Dyspnoea—Alitretinoin—peripheral nervous system neoplasm	7.72e-05	0.000881	CcSEcCtD
Trabectedin—Diarrhoea—Melphalan—peripheral nervous system neoplasm	7.72e-05	0.000881	CcSEcCtD
Trabectedin—Myalgia—Cisplatin—peripheral nervous system neoplasm	7.7e-05	0.000879	CcSEcCtD
Trabectedin—Anaemia—Etoposide—peripheral nervous system neoplasm	7.65e-05	0.000874	CcSEcCtD
Trabectedin—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—peripheral nervous system neoplasm	7.64e-05	0.000873	CcSEcCtD
Trabectedin—Gastrointestinal pain—Dactinomycin—peripheral nervous system neoplasm	7.64e-05	0.000872	CcSEcCtD
Trabectedin—Dyspepsia—Alitretinoin—peripheral nervous system neoplasm	7.62e-05	0.00087	CcSEcCtD
Trabectedin—Dizziness—Topotecan—peripheral nervous system neoplasm	7.62e-05	0.000869	CcSEcCtD
Trabectedin—Musculoskeletal discomfort—Vincristine—peripheral nervous system neoplasm	7.6e-05	0.000868	CcSEcCtD
Trabectedin—Dizziness—Tretinoin—peripheral nervous system neoplasm	7.55e-05	0.000863	CcSEcCtD
Trabectedin—Dizziness—Isotretinoin—peripheral nervous system neoplasm	7.55e-05	0.000863	CcSEcCtD
Trabectedin—Insomnia—Vincristine—peripheral nervous system neoplasm	7.55e-05	0.000862	CcSEcCtD
Trabectedin—Decreased appetite—Alitretinoin—peripheral nervous system neoplasm	7.53e-05	0.000859	CcSEcCtD
Trabectedin—Paraesthesia—Vincristine—peripheral nervous system neoplasm	7.49e-05	0.000855	CcSEcCtD
Trabectedin—Gastrointestinal disorder—Alitretinoin—peripheral nervous system neoplasm	7.48e-05	0.000853	CcSEcCtD
Trabectedin—Fatigue—Alitretinoin—peripheral nervous system neoplasm	7.46e-05	0.000852	CcSEcCtD
Trabectedin—Leukopenia—Etoposide—peripheral nervous system neoplasm	7.41e-05	0.000846	CcSEcCtD
Trabectedin—Constipation—Alitretinoin—peripheral nervous system neoplasm	7.4e-05	0.000845	CcSEcCtD
Trabectedin—Abdominal pain—Dactinomycin—peripheral nervous system neoplasm	7.38e-05	0.000843	CcSEcCtD
Trabectedin—Body temperature increased—Dactinomycin—peripheral nervous system neoplasm	7.38e-05	0.000843	CcSEcCtD
Trabectedin—Oedema—Cisplatin—peripheral nervous system neoplasm	7.38e-05	0.000842	CcSEcCtD
Trabectedin—Infection—Cisplatin—peripheral nervous system neoplasm	7.33e-05	0.000837	CcSEcCtD
Trabectedin—Vomiting—Topotecan—peripheral nervous system neoplasm	7.32e-05	0.000836	CcSEcCtD
Trabectedin—Loss of consciousness—Etoposide—peripheral nervous system neoplasm	7.28e-05	0.000831	CcSEcCtD
Trabectedin—Vomiting—Tretinoin—peripheral nervous system neoplasm	7.26e-05	0.000829	CcSEcCtD
Trabectedin—Vomiting—Isotretinoin—peripheral nervous system neoplasm	7.26e-05	0.000829	CcSEcCtD
Trabectedin—Rash—Topotecan—peripheral nervous system neoplasm	7.26e-05	0.000829	CcSEcCtD
Trabectedin—Dermatitis—Topotecan—peripheral nervous system neoplasm	7.25e-05	0.000828	CcSEcCtD
Trabectedin—Decreased appetite—Vincristine—peripheral nervous system neoplasm	7.25e-05	0.000828	CcSEcCtD
Trabectedin—Nervous system disorder—Cisplatin—peripheral nervous system neoplasm	7.23e-05	0.000826	CcSEcCtD
Trabectedin—Cough—Etoposide—peripheral nervous system neoplasm	7.23e-05	0.000825	CcSEcCtD
Trabectedin—Thrombocytopenia—Cisplatin—peripheral nervous system neoplasm	7.22e-05	0.000825	CcSEcCtD
Trabectedin—Blood creatinine increased—Epirubicin—peripheral nervous system neoplasm	7.22e-05	0.000824	CcSEcCtD
Trabectedin—Headache—Topotecan—peripheral nervous system neoplasm	7.21e-05	0.000824	CcSEcCtD
Trabectedin—Rash—Tretinoin—peripheral nervous system neoplasm	7.2e-05	0.000822	CcSEcCtD
Trabectedin—Rash—Isotretinoin—peripheral nervous system neoplasm	7.2e-05	0.000822	CcSEcCtD
Trabectedin—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	7.2e-05	0.000822	CcSEcCtD
Trabectedin—Dermatitis—Tretinoin—peripheral nervous system neoplasm	7.2e-05	0.000822	CcSEcCtD
Trabectedin—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	7.2e-05	0.000822	CcSEcCtD
Trabectedin—Fatigue—Vincristine—peripheral nervous system neoplasm	7.19e-05	0.000821	CcSEcCtD
Trabectedin—Vomiting—Melphalan—peripheral nervous system neoplasm	7.17e-05	0.000819	CcSEcCtD
Trabectedin—Dehydration—Epirubicin—peripheral nervous system neoplasm	7.17e-05	0.000818	CcSEcCtD
Trabectedin—Skin disorder—Cisplatin—peripheral nervous system neoplasm	7.17e-05	0.000818	CcSEcCtD
Trabectedin—Headache—Tretinoin—peripheral nervous system neoplasm	7.16e-05	0.000817	CcSEcCtD
Trabectedin—Headache—Isotretinoin—peripheral nervous system neoplasm	7.16e-05	0.000817	CcSEcCtD
Trabectedin—Constipation—Vincristine—peripheral nervous system neoplasm	7.13e-05	0.000815	CcSEcCtD
Trabectedin—Rash—Melphalan—peripheral nervous system neoplasm	7.11e-05	0.000812	CcSEcCtD
Trabectedin—Dermatitis—Melphalan—peripheral nervous system neoplasm	7.1e-05	0.000811	CcSEcCtD
Trabectedin—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	7.08e-05	0.000808	CcSEcCtD
Trabectedin—Abdominal pain upper—Epirubicin—peripheral nervous system neoplasm	7.04e-05	0.000804	CcSEcCtD
Trabectedin—Anorexia—Cisplatin—peripheral nervous system neoplasm	7.03e-05	0.000803	CcSEcCtD
Trabectedin—Hypokalaemia—Epirubicin—peripheral nervous system neoplasm	7.02e-05	0.000801	CcSEcCtD
Trabectedin—Unspecified disorder of skin and subcutaneous tissue—Etoposide—peripheral nervous system neoplasm	7e-05	0.000799	CcSEcCtD
Trabectedin—Aspartate aminotransferase increased—Epirubicin—peripheral nervous system neoplasm	6.94e-05	0.000792	CcSEcCtD
Trabectedin—Hypotension—Cisplatin—peripheral nervous system neoplasm	6.89e-05	0.000787	CcSEcCtD
Trabectedin—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	6.88e-05	0.000785	CcSEcCtD
Trabectedin—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	6.84e-05	0.000781	CcSEcCtD
Trabectedin—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	6.84e-05	0.000781	CcSEcCtD
Trabectedin—Nausea—Topotecan—peripheral nervous system neoplasm	6.84e-05	0.000781	CcSEcCtD
Trabectedin—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	6.82e-05	0.000779	CcSEcCtD
Trabectedin—Alanine aminotransferase increased—Epirubicin—peripheral nervous system neoplasm	6.8e-05	0.000776	CcSEcCtD
Trabectedin—Nausea—Isotretinoin—peripheral nervous system neoplasm	6.79e-05	0.000775	CcSEcCtD
Trabectedin—Nausea—Tretinoin—peripheral nervous system neoplasm	6.79e-05	0.000775	CcSEcCtD
Trabectedin—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	6.72e-05	0.000767	CcSEcCtD
Trabectedin—Infection—Etoposide—peripheral nervous system neoplasm	6.71e-05	0.000767	CcSEcCtD
Trabectedin—Asthenia—Dactinomycin—peripheral nervous system neoplasm	6.7e-05	0.000765	CcSEcCtD
Trabectedin—Nausea—Melphalan—peripheral nervous system neoplasm	6.7e-05	0.000765	CcSEcCtD
Trabectedin—Blood creatinine increased—Doxorubicin—peripheral nervous system neoplasm	6.68e-05	0.000763	CcSEcCtD
Trabectedin—Dehydration—Doxorubicin—peripheral nervous system neoplasm	6.63e-05	0.000757	CcSEcCtD
Trabectedin—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	6.62e-05	0.000756	CcSEcCtD
Trabectedin—Thrombocytopenia—Etoposide—peripheral nervous system neoplasm	6.62e-05	0.000755	CcSEcCtD
Trabectedin—Body temperature increased—Vincristine—peripheral nervous system neoplasm	6.6e-05	0.000753	CcSEcCtD
Trabectedin—Abdominal pain—Vincristine—peripheral nervous system neoplasm	6.6e-05	0.000753	CcSEcCtD
Trabectedin—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	6.58e-05	0.000751	CcSEcCtD
Trabectedin—Skin disorder—Etoposide—peripheral nervous system neoplasm	6.56e-05	0.000749	CcSEcCtD
Trabectedin—Abdominal pain upper—Doxorubicin—peripheral nervous system neoplasm	6.51e-05	0.000744	CcSEcCtD
Trabectedin—Hypokalaemia—Doxorubicin—peripheral nervous system neoplasm	6.49e-05	0.000741	CcSEcCtD
Trabectedin—Anorexia—Etoposide—peripheral nervous system neoplasm	6.44e-05	0.000736	CcSEcCtD
Trabectedin—Aspartate aminotransferase increased—Doxorubicin—peripheral nervous system neoplasm	6.42e-05	0.000733	CcSEcCtD
Trabectedin—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	6.41e-05	0.000732	CcSEcCtD
Trabectedin—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	6.39e-05	0.000729	CcSEcCtD
Trabectedin—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	6.38e-05	0.000728	CcSEcCtD
Trabectedin—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	6.37e-05	0.000727	CcSEcCtD
Trabectedin—Pancytopenia—Epirubicin—peripheral nervous system neoplasm	6.33e-05	0.000722	CcSEcCtD
Trabectedin—Hypotension—Etoposide—peripheral nervous system neoplasm	6.32e-05	0.000721	CcSEcCtD
Trabectedin—Alanine aminotransferase increased—Doxorubicin—peripheral nervous system neoplasm	6.29e-05	0.000718	CcSEcCtD
Trabectedin—Neutropenia—Epirubicin—peripheral nervous system neoplasm	6.23e-05	0.000711	CcSEcCtD
Trabectedin—Asthenia—Alitretinoin—peripheral nervous system neoplasm	6.21e-05	0.000709	CcSEcCtD
Trabectedin—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	6.15e-05	0.000702	CcSEcCtD
Trabectedin—Paraesthesia—Etoposide—peripheral nervous system neoplasm	6.07e-05	0.000693	CcSEcCtD
Trabectedin—Weight decreased—Epirubicin—peripheral nervous system neoplasm	6.03e-05	0.000688	CcSEcCtD
Trabectedin—Dyspnoea—Etoposide—peripheral nervous system neoplasm	6.03e-05	0.000688	CcSEcCtD
Trabectedin—Asthenia—Vincristine—peripheral nervous system neoplasm	5.99e-05	0.000683	CcSEcCtD
Trabectedin—Infestation NOS—Epirubicin—peripheral nervous system neoplasm	5.94e-05	0.000678	CcSEcCtD
Trabectedin—Infestation—Epirubicin—peripheral nervous system neoplasm	5.94e-05	0.000678	CcSEcCtD
Trabectedin—Vomiting—Dactinomycin—peripheral nervous system neoplasm	5.94e-05	0.000678	CcSEcCtD
Trabectedin—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	5.92e-05	0.000676	CcSEcCtD
Trabectedin—Rash—Dactinomycin—peripheral nervous system neoplasm	5.89e-05	0.000672	CcSEcCtD
Trabectedin—Decreased appetite—Etoposide—peripheral nervous system neoplasm	5.88e-05	0.000671	CcSEcCtD
Trabectedin—Pancytopenia—Doxorubicin—peripheral nervous system neoplasm	5.85e-05	0.000668	CcSEcCtD
Trabectedin—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	5.83e-05	0.000666	CcSEcCtD
Trabectedin—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	5.83e-05	0.000666	CcSEcCtD
Trabectedin—Fatigue—Etoposide—peripheral nervous system neoplasm	5.83e-05	0.000665	CcSEcCtD
Trabectedin—Stomatitis—Epirubicin—peripheral nervous system neoplasm	5.79e-05	0.000661	CcSEcCtD
Trabectedin—Jaundice—Epirubicin—peripheral nervous system neoplasm	5.79e-05	0.000661	CcSEcCtD
Trabectedin—Constipation—Etoposide—peripheral nervous system neoplasm	5.78e-05	0.00066	CcSEcCtD
Trabectedin—Neutropenia—Doxorubicin—peripheral nervous system neoplasm	5.76e-05	0.000658	CcSEcCtD
Trabectedin—Dizziness—Alitretinoin—peripheral nervous system neoplasm	5.73e-05	0.000654	CcSEcCtD
Trabectedin—Diarrhoea—Vincristine—peripheral nervous system neoplasm	5.71e-05	0.000652	CcSEcCtD
Trabectedin—Hepatobiliary disease—Epirubicin—peripheral nervous system neoplasm	5.62e-05	0.000641	CcSEcCtD
Trabectedin—Weight decreased—Doxorubicin—peripheral nervous system neoplasm	5.58e-05	0.000637	CcSEcCtD
Trabectedin—Nausea—Dactinomycin—peripheral nervous system neoplasm	5.55e-05	0.000633	CcSEcCtD
Trabectedin—Agranulocytosis—Epirubicin—peripheral nervous system neoplasm	5.54e-05	0.000633	CcSEcCtD
Trabectedin—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	5.53e-05	0.000631	CcSEcCtD
Trabectedin—Dizziness—Vincristine—peripheral nervous system neoplasm	5.52e-05	0.00063	CcSEcCtD
Trabectedin—Vomiting—Alitretinoin—peripheral nervous system neoplasm	5.51e-05	0.000629	CcSEcCtD
Trabectedin—Infestation—Doxorubicin—peripheral nervous system neoplasm	5.5e-05	0.000627	CcSEcCtD
Trabectedin—Infestation NOS—Doxorubicin—peripheral nervous system neoplasm	5.5e-05	0.000627	CcSEcCtD
Trabectedin—Rash—Alitretinoin—peripheral nervous system neoplasm	5.46e-05	0.000623	CcSEcCtD
Trabectedin—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	5.45e-05	0.000623	CcSEcCtD
Trabectedin—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	5.44e-05	0.000621	CcSEcCtD
Trabectedin—Headache—Alitretinoin—peripheral nervous system neoplasm	5.42e-05	0.000619	CcSEcCtD
Trabectedin—Haemoglobin—Epirubicin—peripheral nervous system neoplasm	5.36e-05	0.000612	CcSEcCtD
Trabectedin—Stomatitis—Doxorubicin—peripheral nervous system neoplasm	5.36e-05	0.000612	CcSEcCtD
Trabectedin—Jaundice—Doxorubicin—peripheral nervous system neoplasm	5.36e-05	0.000612	CcSEcCtD
Trabectedin—Abdominal pain—Etoposide—peripheral nervous system neoplasm	5.34e-05	0.00061	CcSEcCtD
Trabectedin—Body temperature increased—Etoposide—peripheral nervous system neoplasm	5.34e-05	0.00061	CcSEcCtD
Trabectedin—Haemorrhage—Epirubicin—peripheral nervous system neoplasm	5.33e-05	0.000609	CcSEcCtD
Trabectedin—Vomiting—Vincristine—peripheral nervous system neoplasm	5.3e-05	0.000606	CcSEcCtD
Trabectedin—Asthenia—Cisplatin—peripheral nervous system neoplasm	5.29e-05	0.000604	CcSEcCtD
Trabectedin—Rash—Vincristine—peripheral nervous system neoplasm	5.26e-05	0.000601	CcSEcCtD
Trabectedin—Dermatitis—Vincristine—peripheral nervous system neoplasm	5.26e-05	0.0006	CcSEcCtD
Trabectedin—Oedema peripheral—Epirubicin—peripheral nervous system neoplasm	5.25e-05	0.0006	CcSEcCtD
Trabectedin—Connective tissue disorder—Epirubicin—peripheral nervous system neoplasm	5.24e-05	0.000598	CcSEcCtD
Trabectedin—Headache—Vincristine—peripheral nervous system neoplasm	5.23e-05	0.000597	CcSEcCtD
Trabectedin—Hepatobiliary disease—Doxorubicin—peripheral nervous system neoplasm	5.2e-05	0.000593	CcSEcCtD
Trabectedin—Nausea—Alitretinoin—peripheral nervous system neoplasm	5.14e-05	0.000587	CcSEcCtD
Trabectedin—Agranulocytosis—Doxorubicin—peripheral nervous system neoplasm	5.13e-05	0.000586	CcSEcCtD
Trabectedin—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	5.05e-05	0.000576	CcSEcCtD
Trabectedin—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	4.98e-05	0.000568	CcSEcCtD
Trabectedin—Haemoglobin—Doxorubicin—peripheral nervous system neoplasm	4.96e-05	0.000566	CcSEcCtD
Trabectedin—Nausea—Vincristine—peripheral nervous system neoplasm	4.96e-05	0.000566	CcSEcCtD
Trabectedin—Flushing—Epirubicin—peripheral nervous system neoplasm	4.95e-05	0.000565	CcSEcCtD
Trabectedin—Haemorrhage—Doxorubicin—peripheral nervous system neoplasm	4.93e-05	0.000563	CcSEcCtD
Trabectedin—Oedema peripheral—Doxorubicin—peripheral nervous system neoplasm	4.86e-05	0.000555	CcSEcCtD
Trabectedin—Asthenia—Etoposide—peripheral nervous system neoplasm	4.85e-05	0.000554	CcSEcCtD
Trabectedin—Connective tissue disorder—Doxorubicin—peripheral nervous system neoplasm	4.85e-05	0.000554	CcSEcCtD
Trabectedin—Angiopathy—Epirubicin—peripheral nervous system neoplasm	4.84e-05	0.000552	CcSEcCtD
Trabectedin—Mediastinal disorder—Epirubicin—peripheral nervous system neoplasm	4.81e-05	0.000549	CcSEcCtD
Trabectedin—Alopecia—Epirubicin—peripheral nervous system neoplasm	4.71e-05	0.000538	CcSEcCtD
Trabectedin—Vomiting—Cisplatin—peripheral nervous system neoplasm	4.69e-05	0.000536	CcSEcCtD
Trabectedin—Mental disorder—Epirubicin—peripheral nervous system neoplasm	4.67e-05	0.000533	CcSEcCtD
Trabectedin—Rash—Cisplatin—peripheral nervous system neoplasm	4.65e-05	0.000531	CcSEcCtD
Trabectedin—Dermatitis—Cisplatin—peripheral nervous system neoplasm	4.65e-05	0.000531	CcSEcCtD
Trabectedin—Malnutrition—Epirubicin—peripheral nervous system neoplasm	4.64e-05	0.00053	CcSEcCtD
Trabectedin—Diarrhoea—Etoposide—peripheral nervous system neoplasm	4.62e-05	0.000528	CcSEcCtD
Trabectedin—Flushing—Doxorubicin—peripheral nervous system neoplasm	4.58e-05	0.000523	CcSEcCtD
Trabectedin—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	4.55e-05	0.000519	CcSEcCtD
Trabectedin—Back pain—Epirubicin—peripheral nervous system neoplasm	4.49e-05	0.000513	CcSEcCtD
Trabectedin—Angiopathy—Doxorubicin—peripheral nervous system neoplasm	4.48e-05	0.000511	CcSEcCtD
Trabectedin—Dizziness—Etoposide—peripheral nervous system neoplasm	4.47e-05	0.00051	CcSEcCtD
Trabectedin—Mediastinal disorder—Doxorubicin—peripheral nervous system neoplasm	4.45e-05	0.000508	CcSEcCtD
Trabectedin—Nausea—Cisplatin—peripheral nervous system neoplasm	4.38e-05	0.0005	CcSEcCtD
Trabectedin—Alopecia—Doxorubicin—peripheral nervous system neoplasm	4.36e-05	0.000498	CcSEcCtD
Trabectedin—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	4.32e-05	0.000494	CcSEcCtD
Trabectedin—Vomiting—Etoposide—peripheral nervous system neoplasm	4.3e-05	0.000491	CcSEcCtD
Trabectedin—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	4.3e-05	0.00049	CcSEcCtD
Trabectedin—Anaemia—Epirubicin—peripheral nervous system neoplasm	4.29e-05	0.00049	CcSEcCtD
Trabectedin—Rash—Etoposide—peripheral nervous system neoplasm	4.26e-05	0.000487	CcSEcCtD
Trabectedin—Dermatitis—Etoposide—peripheral nervous system neoplasm	4.26e-05	0.000486	CcSEcCtD
Trabectedin—Headache—Etoposide—peripheral nervous system neoplasm	4.23e-05	0.000483	CcSEcCtD
Trabectedin—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	4.21e-05	0.00048	CcSEcCtD
Trabectedin—Syncope—Epirubicin—peripheral nervous system neoplasm	4.16e-05	0.000475	CcSEcCtD
Trabectedin—Leukopenia—Epirubicin—peripheral nervous system neoplasm	4.16e-05	0.000474	CcSEcCtD
Trabectedin—Back pain—Doxorubicin—peripheral nervous system neoplasm	4.15e-05	0.000474	CcSEcCtD
Trabectedin—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	4.08e-05	0.000466	CcSEcCtD
Trabectedin—Cough—Epirubicin—peripheral nervous system neoplasm	4.05e-05	0.000462	CcSEcCtD
Trabectedin—Nausea—Etoposide—peripheral nervous system neoplasm	4.01e-05	0.000458	CcSEcCtD
Trabectedin—Anaemia—Doxorubicin—peripheral nervous system neoplasm	3.97e-05	0.000453	CcSEcCtD
Trabectedin—Myalgia—Epirubicin—peripheral nervous system neoplasm	3.95e-05	0.000451	CcSEcCtD
Trabectedin—Arthralgia—Epirubicin—peripheral nervous system neoplasm	3.95e-05	0.000451	CcSEcCtD
Trabectedin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	3.92e-05	0.000448	CcSEcCtD
Trabectedin—Syncope—Doxorubicin—peripheral nervous system neoplasm	3.85e-05	0.00044	CcSEcCtD
Trabectedin—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	3.84e-05	0.000439	CcSEcCtD
Trabectedin—Oedema—Epirubicin—peripheral nervous system neoplasm	3.79e-05	0.000433	CcSEcCtD
Trabectedin—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	3.78e-05	0.000431	CcSEcCtD
Trabectedin—Infection—Epirubicin—peripheral nervous system neoplasm	3.76e-05	0.00043	CcSEcCtD
Trabectedin—Cough—Doxorubicin—peripheral nervous system neoplasm	3.75e-05	0.000428	CcSEcCtD
Trabectedin—Shock—Epirubicin—peripheral nervous system neoplasm	3.73e-05	0.000426	CcSEcCtD
Trabectedin—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	3.72e-05	0.000424	CcSEcCtD
Trabectedin—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	3.71e-05	0.000423	CcSEcCtD
Trabectedin—Skin disorder—Epirubicin—peripheral nervous system neoplasm	3.68e-05	0.00042	CcSEcCtD
Trabectedin—Myalgia—Doxorubicin—peripheral nervous system neoplasm	3.66e-05	0.000417	CcSEcCtD
Trabectedin—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	3.66e-05	0.000417	CcSEcCtD
Trabectedin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	3.63e-05	0.000415	CcSEcCtD
Trabectedin—Anorexia—Epirubicin—peripheral nervous system neoplasm	3.61e-05	0.000412	CcSEcCtD
Trabectedin—Hypotension—Epirubicin—peripheral nervous system neoplasm	3.54e-05	0.000404	CcSEcCtD
Trabectedin—Oedema—Doxorubicin—peripheral nervous system neoplasm	3.51e-05	0.0004	CcSEcCtD
Trabectedin—Infection—Doxorubicin—peripheral nervous system neoplasm	3.48e-05	0.000398	CcSEcCtD
Trabectedin—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	3.45e-05	0.000394	CcSEcCtD
Trabectedin—Shock—Doxorubicin—peripheral nervous system neoplasm	3.45e-05	0.000394	CcSEcCtD
Trabectedin—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	3.44e-05	0.000392	CcSEcCtD
Trabectedin—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	3.43e-05	0.000392	CcSEcCtD
Trabectedin—Insomnia—Epirubicin—peripheral nervous system neoplasm	3.43e-05	0.000391	CcSEcCtD
Trabectedin—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	3.4e-05	0.000389	CcSEcCtD
Trabectedin—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	3.4e-05	0.000388	CcSEcCtD
Trabectedin—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	3.38e-05	0.000386	CcSEcCtD
Trabectedin—Anorexia—Doxorubicin—peripheral nervous system neoplasm	3.34e-05	0.000381	CcSEcCtD
Trabectedin—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	3.33e-05	0.000381	CcSEcCtD
Trabectedin—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	3.29e-05	0.000376	CcSEcCtD
Trabectedin—Hypotension—Doxorubicin—peripheral nervous system neoplasm	3.28e-05	0.000374	CcSEcCtD
Trabectedin—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	3.27e-05	0.000373	CcSEcCtD
Trabectedin—Fatigue—Epirubicin—peripheral nervous system neoplasm	3.27e-05	0.000373	CcSEcCtD
Trabectedin—Constipation—Epirubicin—peripheral nervous system neoplasm	3.24e-05	0.00037	CcSEcCtD
Trabectedin—SRC—Oncostatin M Signaling Pathway—HRAS—peripheral nervous system neoplasm	3.21e-05	0.00134	CbGpPWpGaD
Trabectedin—SRC—Signaling by PDGF—PTPN11—peripheral nervous system neoplasm	3.2e-05	0.00134	CbGpPWpGaD
Trabectedin—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	3.19e-05	0.000365	CcSEcCtD
Trabectedin—SRC—Thromboxane A2 receptor signaling—AKT1—peripheral nervous system neoplasm	3.19e-05	0.00134	CbGpPWpGaD
Trabectedin—Insomnia—Doxorubicin—peripheral nervous system neoplasm	3.17e-05	0.000362	CcSEcCtD
Trabectedin—SRC—TSH signaling pathway—HRAS—peripheral nervous system neoplasm	3.17e-05	0.00133	CbGpPWpGaD
Trabectedin—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	3.15e-05	0.000359	CcSEcCtD
Trabectedin—SRC—Cell surface interactions at the vascular wall—NRAS—peripheral nervous system neoplasm	3.13e-05	0.00131	CbGpPWpGaD
Trabectedin—SRC—Rac1/Pak1/p38/MMP-2 pathway—HRAS—peripheral nervous system neoplasm	3.13e-05	0.00131	CbGpPWpGaD
Trabectedin—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	3.13e-05	0.000357	CcSEcCtD
Trabectedin—SRC—Signaling by SCF-KIT—ERBB2—peripheral nervous system neoplasm	3.1e-05	0.0013	CbGpPWpGaD
Trabectedin—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	3.1e-05	0.000354	CcSEcCtD
Trabectedin—SRC—NCAM signaling for neurite out-growth—HRAS—peripheral nervous system neoplasm	3.09e-05	0.0013	CbGpPWpGaD
Trabectedin—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	3.09e-05	0.000352	CcSEcCtD
Trabectedin—SRC—Kit receptor signaling pathway—AKT1—peripheral nervous system neoplasm	3.06e-05	0.00128	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—HSD17B12—peripheral nervous system neoplasm	3.05e-05	0.00128	CbGpPWpGaD
Trabectedin—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	3.05e-05	0.000348	CcSEcCtD
Trabectedin—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	3.03e-05	0.000346	CcSEcCtD
Trabectedin—SRC—CDC42 signaling events—HRAS—peripheral nervous system neoplasm	3.02e-05	0.00127	CbGpPWpGaD
Trabectedin—Fatigue—Doxorubicin—peripheral nervous system neoplasm	3.02e-05	0.000345	CcSEcCtD
Trabectedin—Constipation—Doxorubicin—peripheral nervous system neoplasm	3e-05	0.000342	CcSEcCtD
Trabectedin—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	2.99e-05	0.000342	CcSEcCtD
Trabectedin—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	2.99e-05	0.000342	CcSEcCtD
Trabectedin—SRC—ErbB1 downstream signaling—NRAS—peripheral nervous system neoplasm	2.99e-05	0.00125	CbGpPWpGaD
Trabectedin—SRC—Notch Signaling Pathway—AKT1—peripheral nervous system neoplasm	2.98e-05	0.00125	CbGpPWpGaD
Trabectedin—SRC—VEGFA-VEGFR2 Pathway—NRAS—peripheral nervous system neoplasm	2.94e-05	0.00123	CbGpPWpGaD
Trabectedin—SRC—Endothelins—AKT1—peripheral nervous system neoplasm	2.9e-05	0.00122	CbGpPWpGaD
Trabectedin—SRC—Integrins in angiogenesis—AKT1—peripheral nervous system neoplasm	2.9e-05	0.00122	CbGpPWpGaD
Trabectedin—SRC—NGF signalling via TRKA from the plasma membrane—PTPN11—peripheral nervous system neoplasm	2.9e-05	0.00121	CbGpPWpGaD
Trabectedin—SRC—LPA receptor mediated events—AKT1—peripheral nervous system neoplasm	2.87e-05	0.0012	CbGpPWpGaD
Trabectedin—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	2.87e-05	0.000327	CcSEcCtD
Trabectedin—SRC—Leptin signaling pathway—HRAS—peripheral nervous system neoplasm	2.86e-05	0.0012	CbGpPWpGaD
Trabectedin—SRC—Oncostatin M Signaling Pathway—AKT1—peripheral nervous system neoplasm	2.83e-05	0.00119	CbGpPWpGaD
Trabectedin—SRC—AGE/RAGE pathway—AKT1—peripheral nervous system neoplasm	2.8e-05	0.00117	CbGpPWpGaD
Trabectedin—SRC—TSH signaling pathway—AKT1—peripheral nervous system neoplasm	2.8e-05	0.00117	CbGpPWpGaD
Trabectedin—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	2.79e-05	0.000319	CcSEcCtD
Trabectedin—SRC—Downstream signal transduction—ERBB2—peripheral nervous system neoplasm	2.79e-05	0.00117	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways in Glioblastoma—TP53—peripheral nervous system neoplasm	2.79e-05	0.00117	CbGpPWpGaD
Trabectedin—SRC—Signaling by VEGF—NRAS—peripheral nervous system neoplasm	2.78e-05	0.00116	CbGpPWpGaD
Trabectedin—SRC—EGF/EGFR Signaling Pathway—ERBB2—peripheral nervous system neoplasm	2.78e-05	0.00116	CbGpPWpGaD
Trabectedin—SRC—Signaling by FGFR—ERBB2—peripheral nervous system neoplasm	2.78e-05	0.00116	CbGpPWpGaD
Trabectedin—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	2.77e-05	0.000316	CcSEcCtD
Trabectedin—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	2.77e-05	0.000316	CcSEcCtD
Trabectedin—SRC—BDNF signaling pathway—CASP3—peripheral nervous system neoplasm	2.77e-05	0.00116	CbGpPWpGaD
Trabectedin—SRC—Rac1/Pak1/p38/MMP-2 pathway—AKT1—peripheral nervous system neoplasm	2.77e-05	0.00116	CbGpPWpGaD
Trabectedin—SRC—Signaling by ERBB2—ERBB2—peripheral nervous system neoplasm	2.76e-05	0.00116	CbGpPWpGaD
Trabectedin—SRC—Costimulation by the CD28 family—AKT1—peripheral nervous system neoplasm	2.73e-05	0.00114	CbGpPWpGaD
Trabectedin—SRC—Signaling events mediated by VEGFR1 and VEGFR2—AKT1—peripheral nervous system neoplasm	2.73e-05	0.00114	CbGpPWpGaD
Trabectedin—Asthenia—Epirubicin—peripheral nervous system neoplasm	2.72e-05	0.00031	CcSEcCtD
Trabectedin—SRC—Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met)—HRAS—peripheral nervous system neoplasm	2.72e-05	0.00114	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways in Glioblastoma—HRAS—peripheral nervous system neoplasm	2.66e-05	0.00112	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—PPIP5K2—peripheral nervous system neoplasm	2.6e-05	0.00109	CbGpPWpGaD
Trabectedin—SRC—Immune System—CD55—peripheral nervous system neoplasm	2.6e-05	0.00109	CbGpPWpGaD
Trabectedin—SRC—PDGFR-beta signaling pathway—NRAS—peripheral nervous system neoplasm	2.6e-05	0.00109	CbGpPWpGaD
Trabectedin—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	2.59e-05	0.000296	CcSEcCtD
Trabectedin—SRC—Signaling by FGFR in disease—ERBB2—peripheral nervous system neoplasm	2.59e-05	0.00108	CbGpPWpGaD
Trabectedin—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	2.58e-05	0.000295	CcSEcCtD
Trabectedin—SRC—Signaling by EGFR—ERBB2—peripheral nervous system neoplasm	2.56e-05	0.00107	CbGpPWpGaD
Trabectedin—SRC—Signaling by EGFR in Cancer—ERBB2—peripheral nervous system neoplasm	2.54e-05	0.00106	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	2.53e-05	0.00106	CbGpPWpGaD
Trabectedin—SRC—Signaling by PDGF—ERBB2—peripheral nervous system neoplasm	2.53e-05	0.00106	CbGpPWpGaD
Trabectedin—SRC—Leptin signaling pathway—AKT1—peripheral nervous system neoplasm	2.53e-05	0.00106	CbGpPWpGaD
Trabectedin—Asthenia—Doxorubicin—peripheral nervous system neoplasm	2.52e-05	0.000287	CcSEcCtD
Trabectedin—SRC—Hemostasis—IFNB1—peripheral nervous system neoplasm	2.51e-05	0.00105	CbGpPWpGaD
Trabectedin—Dizziness—Epirubicin—peripheral nervous system neoplasm	2.51e-05	0.000286	CcSEcCtD
Trabectedin—SRC—Disease—GNS—peripheral nervous system neoplasm	2.5e-05	0.00105	CbGpPWpGaD
Trabectedin—SRC—Focal Adhesion—ERBB2—peripheral nervous system neoplasm	2.44e-05	0.00102	CbGpPWpGaD
Trabectedin—SRC—Integrated Pancreatic Cancer Pathway—ERBB2—peripheral nervous system neoplasm	2.43e-05	0.00102	CbGpPWpGaD
Trabectedin—SRC—PDGFR-beta signaling pathway—MYC—peripheral nervous system neoplasm	2.42e-05	0.00101	CbGpPWpGaD
Trabectedin—Vomiting—Epirubicin—peripheral nervous system neoplasm	2.41e-05	0.000275	CcSEcCtD
Trabectedin—SRC—Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met)—AKT1—peripheral nervous system neoplasm	2.4e-05	0.001	CbGpPWpGaD
Trabectedin—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	2.4e-05	0.000274	CcSEcCtD
Trabectedin—CYP2D6—Metabolism—PPIP5K2—peripheral nervous system neoplasm	2.39e-05	0.001	CbGpPWpGaD
Trabectedin—Rash—Epirubicin—peripheral nervous system neoplasm	2.39e-05	0.000273	CcSEcCtD
Trabectedin—SRC—EPH-Ephrin signaling—HRAS—peripheral nervous system neoplasm	2.39e-05	0.001	CbGpPWpGaD
Trabectedin—Dermatitis—Epirubicin—peripheral nervous system neoplasm	2.39e-05	0.000272	CcSEcCtD
Trabectedin—CYP2C9—Metabolism—PPIP5K2—peripheral nervous system neoplasm	2.37e-05	0.000994	CbGpPWpGaD
Trabectedin—Headache—Epirubicin—peripheral nervous system neoplasm	2.37e-05	0.000271	CcSEcCtD
Trabectedin—SRC—Signaling by SCF-KIT—NRAS—peripheral nervous system neoplasm	2.36e-05	0.000988	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways in Glioblastoma—AKT1—peripheral nervous system neoplasm	2.35e-05	0.000985	CbGpPWpGaD
Trabectedin—SRC—Hemostasis—KNG1—peripheral nervous system neoplasm	2.32e-05	0.000973	CbGpPWpGaD
Trabectedin—Dizziness—Doxorubicin—peripheral nervous system neoplasm	2.32e-05	0.000265	CcSEcCtD
Trabectedin—SRC—TGF-beta Signaling Pathway—MYC—peripheral nervous system neoplasm	2.32e-05	0.00097	CbGpPWpGaD
Trabectedin—SRC—CXCR4-mediated signaling events—AKT1—peripheral nervous system neoplasm	2.31e-05	0.000966	CbGpPWpGaD
Trabectedin—SRC—Cell surface interactions at the vascular wall—HRAS—peripheral nervous system neoplasm	2.29e-05	0.000959	CbGpPWpGaD
Trabectedin—SRC—NGF signalling via TRKA from the plasma membrane—ERBB2—peripheral nervous system neoplasm	2.29e-05	0.000959	CbGpPWpGaD
Trabectedin—SRC—Senescence and Autophagy in Cancer—TP53—peripheral nervous system neoplasm	2.29e-05	0.000957	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—HSD17B12—peripheral nervous system neoplasm	2.28e-05	0.000954	CbGpPWpGaD
Trabectedin—SRC—Integrin-mediated Cell Adhesion—HRAS—peripheral nervous system neoplasm	2.27e-05	0.000952	CbGpPWpGaD
Trabectedin—SRC—Innate Immune System—IFNB1—peripheral nervous system neoplasm	2.26e-05	0.000945	CbGpPWpGaD
Trabectedin—Nausea—Epirubicin—peripheral nervous system neoplasm	2.25e-05	0.000257	CcSEcCtD
Trabectedin—SRC—Signaling by NGF—PTPN11—peripheral nervous system neoplasm	2.23e-05	0.000933	CbGpPWpGaD
Trabectedin—Vomiting—Doxorubicin—peripheral nervous system neoplasm	2.23e-05	0.000254	CcSEcCtD
Trabectedin—Rash—Doxorubicin—peripheral nervous system neoplasm	2.21e-05	0.000252	CcSEcCtD
Trabectedin—SRC—Integrated Pancreatic Cancer Pathway—CASP3—peripheral nervous system neoplasm	2.21e-05	0.000925	CbGpPWpGaD
Trabectedin—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	2.21e-05	0.000252	CcSEcCtD
Trabectedin—PTGS1—Metabolism—GNS—peripheral nervous system neoplasm	2.2e-05	0.000923	CbGpPWpGaD
Trabectedin—SRC—Androgen receptor signaling pathway—AKT1—peripheral nervous system neoplasm	2.2e-05	0.000922	CbGpPWpGaD
Trabectedin—Headache—Doxorubicin—peripheral nervous system neoplasm	2.2e-05	0.000251	CcSEcCtD
Trabectedin—SRC—ErbB1 downstream signaling—HRAS—peripheral nervous system neoplasm	2.19e-05	0.000915	CbGpPWpGaD
Trabectedin—SRC—Senescence and Autophagy in Cancer—HRAS—peripheral nervous system neoplasm	2.19e-05	0.000915	CbGpPWpGaD
Trabectedin—SRC—Axon guidance—MET—peripheral nervous system neoplasm	2.18e-05	0.000913	CbGpPWpGaD
Trabectedin—SRC—VEGFA-VEGFR2 Pathway—HRAS—peripheral nervous system neoplasm	2.15e-05	0.000901	CbGpPWpGaD
Trabectedin—SRC—Downstream signal transduction—NRAS—peripheral nervous system neoplasm	2.12e-05	0.000889	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—NME1—peripheral nervous system neoplasm	2.11e-05	0.000885	CbGpPWpGaD
Trabectedin—SRC—Signaling by FGFR—NRAS—peripheral nervous system neoplasm	2.11e-05	0.000884	CbGpPWpGaD
Trabectedin—SRC—Signaling by ERBB2—NRAS—peripheral nervous system neoplasm	2.1e-05	0.00088	CbGpPWpGaD
Trabectedin—Nausea—Doxorubicin—peripheral nervous system neoplasm	2.08e-05	0.000238	CcSEcCtD
Trabectedin—PTGS1—Metabolism—COX2—peripheral nervous system neoplasm	2.03e-05	0.000852	CbGpPWpGaD
Trabectedin—SRC—Signaling by VEGF—HRAS—peripheral nervous system neoplasm	2.03e-05	0.000851	CbGpPWpGaD
Trabectedin—SRC—Hemostasis—GNAS—peripheral nervous system neoplasm	2.03e-05	0.000851	CbGpPWpGaD
Trabectedin—SRC—Axon guidance—PTPN11—peripheral nervous system neoplasm	2.02e-05	0.000845	CbGpPWpGaD
Trabectedin—SRC—Integrin-mediated Cell Adhesion—AKT1—peripheral nervous system neoplasm	2.01e-05	0.00084	CbGpPWpGaD
Trabectedin—SRC—GAB1 signalosome—AKT1—peripheral nervous system neoplasm	1.98e-05	0.000827	CbGpPWpGaD
Trabectedin—SRC—Immune System—CD34—peripheral nervous system neoplasm	1.97e-05	0.000825	CbGpPWpGaD
Trabectedin—SRC—Signaling by FGFR in disease—NRAS—peripheral nervous system neoplasm	1.97e-05	0.000824	CbGpPWpGaD
Trabectedin—SRC—Signaling by EGFR—NRAS—peripheral nervous system neoplasm	1.95e-05	0.000816	CbGpPWpGaD
Trabectedin—SRC—Hemostasis—HGF—peripheral nervous system neoplasm	1.94e-05	0.00081	CbGpPWpGaD
Trabectedin—SRC—Signaling by EGFR in Cancer—NRAS—peripheral nervous system neoplasm	1.93e-05	0.000809	CbGpPWpGaD
Trabectedin—SRC—ErbB1 downstream signaling—AKT1—peripheral nervous system neoplasm	1.93e-05	0.000808	CbGpPWpGaD
Trabectedin—SRC—Signaling by PDGF—NRAS—peripheral nervous system neoplasm	1.92e-05	0.000806	CbGpPWpGaD
Trabectedin—SRC—TGF-beta Signaling Pathway—TP53—peripheral nervous system neoplasm	1.9e-05	0.000797	CbGpPWpGaD
Trabectedin—SRC—PDGFR-beta signaling pathway—HRAS—peripheral nervous system neoplasm	1.9e-05	0.000796	CbGpPWpGaD
Trabectedin—SRC—VEGFA-VEGFR2 Pathway—AKT1—peripheral nervous system neoplasm	1.9e-05	0.000796	CbGpPWpGaD
Trabectedin—SRC—Immune System—PPP3R1—peripheral nervous system neoplasm	1.9e-05	0.000794	CbGpPWpGaD
Trabectedin—SRC—Signaling by VEGF—AKT1—peripheral nervous system neoplasm	1.79e-05	0.000751	CbGpPWpGaD
Trabectedin—SRC—Signaling by NGF—ERBB2—peripheral nervous system neoplasm	1.76e-05	0.000738	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.76e-05	0.000736	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—NTS—peripheral nervous system neoplasm	1.75e-05	0.000734	CbGpPWpGaD
Trabectedin—SRC—Disease—PPP3R1—peripheral nervous system neoplasm	1.75e-05	0.000733	CbGpPWpGaD
Trabectedin—SRC—NGF signalling via TRKA from the plasma membrane—NRAS—peripheral nervous system neoplasm	1.74e-05	0.00073	CbGpPWpGaD
Trabectedin—SRC—Signaling by SCF-KIT—HRAS—peripheral nervous system neoplasm	1.73e-05	0.000723	CbGpPWpGaD
Trabectedin—SRC—Integrated Pancreatic Cancer Pathway—MYC—peripheral nervous system neoplasm	1.72e-05	0.000722	CbGpPWpGaD
Trabectedin—SRC—BDNF signaling pathway—HRAS—peripheral nervous system neoplasm	1.7e-05	0.000711	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—CD55—peripheral nervous system neoplasm	1.68e-05	0.000704	CbGpPWpGaD
Trabectedin—SRC—Immune System—NCAM1—peripheral nervous system neoplasm	1.68e-05	0.000701	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—GNS—peripheral nervous system neoplasm	1.65e-05	0.00069	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.62e-05	0.000677	CbGpPWpGaD
Trabectedin—SRC—TGF-beta Signaling Pathway—AKT1—peripheral nervous system neoplasm	1.61e-05	0.000673	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.6e-05	0.000671	CbGpPWpGaD
Trabectedin—SRC—Signaling by NGF—CASP3—peripheral nervous system neoplasm	1.6e-05	0.000669	CbGpPWpGaD
Trabectedin—SRC—Axon guidance—ERBB2—peripheral nervous system neoplasm	1.59e-05	0.000668	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—NME1—peripheral nervous system neoplasm	1.58e-05	0.000661	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—PPIP5K2—peripheral nervous system neoplasm	1.57e-05	0.000655	CbGpPWpGaD
Trabectedin—SRC—Developmental Biology—MET—peripheral nervous system neoplasm	1.56e-05	0.000652	CbGpPWpGaD
Trabectedin—SRC—Downstream signal transduction—HRAS—peripheral nervous system neoplasm	1.55e-05	0.00065	CbGpPWpGaD
Trabectedin—SRC—Signaling by FGFR—HRAS—peripheral nervous system neoplasm	1.55e-05	0.000647	CbGpPWpGaD
Trabectedin—SRC—EGF/EGFR Signaling Pathway—HRAS—peripheral nervous system neoplasm	1.55e-05	0.000647	CbGpPWpGaD
Trabectedin—SRC—Signaling by ERBB2—HRAS—peripheral nervous system neoplasm	1.54e-05	0.000644	CbGpPWpGaD
Trabectedin—SRC—Signaling by SCF-KIT—AKT1—peripheral nervous system neoplasm	1.52e-05	0.000638	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—COX2—peripheral nervous system neoplasm	1.52e-05	0.000637	CbGpPWpGaD
Trabectedin—SRC—Disease—ENO2—peripheral nervous system neoplasm	1.52e-05	0.000635	CbGpPWpGaD
Trabectedin—SRC—BDNF signaling pathway—AKT1—peripheral nervous system neoplasm	1.5e-05	0.000628	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	1.46e-05	0.000612	CbGpPWpGaD
Trabectedin—SRC—Developmental Biology—PTPN11—peripheral nervous system neoplasm	1.44e-05	0.000603	CbGpPWpGaD
Trabectedin—SRC—Signaling by FGFR in disease—HRAS—peripheral nervous system neoplasm	1.44e-05	0.000603	CbGpPWpGaD
Trabectedin—SRC—Signaling by EGFR—HRAS—peripheral nervous system neoplasm	1.43e-05	0.000597	CbGpPWpGaD
Trabectedin—SRC—Integrated Pancreatic Cancer Pathway—TP53—peripheral nervous system neoplasm	1.42e-05	0.000593	CbGpPWpGaD
Trabectedin—SRC—Signaling by EGFR in Cancer—HRAS—peripheral nervous system neoplasm	1.41e-05	0.000592	CbGpPWpGaD
Trabectedin—SRC—Hemostasis—PTPN11—peripheral nervous system neoplasm	1.41e-05	0.000591	CbGpPWpGaD
Trabectedin—SRC—Signaling by PDGF—HRAS—peripheral nervous system neoplasm	1.41e-05	0.000589	CbGpPWpGaD
Trabectedin—SRC—Downstream signal transduction—AKT1—peripheral nervous system neoplasm	1.37e-05	0.000574	CbGpPWpGaD
Trabectedin—SRC—Signaling by FGFR—AKT1—peripheral nervous system neoplasm	1.36e-05	0.000571	CbGpPWpGaD
Trabectedin—SRC—EGF/EGFR Signaling Pathway—AKT1—peripheral nervous system neoplasm	1.36e-05	0.000571	CbGpPWpGaD
Trabectedin—SRC—Focal Adhesion—HRAS—peripheral nervous system neoplasm	1.36e-05	0.000569	CbGpPWpGaD
Trabectedin—SRC—Signaling by ERBB2—AKT1—peripheral nervous system neoplasm	1.36e-05	0.000568	CbGpPWpGaD
Trabectedin—SRC—Signaling by NGF—NRAS—peripheral nervous system neoplasm	1.34e-05	0.000561	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—ENO2—peripheral nervous system neoplasm	1.34e-05	0.000559	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	1.33e-05	0.000558	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—VIP—peripheral nervous system neoplasm	1.33e-05	0.000556	CbGpPWpGaD
Trabectedin—SRC—Immune System—IFNB1—peripheral nervous system neoplasm	1.31e-05	0.00055	CbGpPWpGaD
Trabectedin—SRC—NGF signalling via TRKA from the plasma membrane—HRAS—peripheral nervous system neoplasm	1.28e-05	0.000534	CbGpPWpGaD
Trabectedin—SRC—Innate Immune System—PTPN11—peripheral nervous system neoplasm	1.27e-05	0.000532	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—GNS—peripheral nervous system neoplasm	1.27e-05	0.000532	CbGpPWpGaD
Trabectedin—SRC—Signaling by FGFR in disease—AKT1—peripheral nervous system neoplasm	1.27e-05	0.000532	CbGpPWpGaD
Trabectedin—SRC—Signaling by EGFR—AKT1—peripheral nervous system neoplasm	1.26e-05	0.000527	CbGpPWpGaD
Trabectedin—SRC—Signaling by EGFR in Cancer—AKT1—peripheral nervous system neoplasm	1.25e-05	0.000523	CbGpPWpGaD
Trabectedin—SRC—Signaling by PDGF—AKT1—peripheral nervous system neoplasm	1.24e-05	0.00052	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	1.23e-05	0.000513	CbGpPWpGaD
Trabectedin—SRC—Disease—SLC2A1—peripheral nervous system neoplasm	1.22e-05	0.000512	CbGpPWpGaD
Trabectedin—SRC—Adaptive Immune System—PTPN11—peripheral nervous system neoplasm	1.22e-05	0.000511	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—NME1—peripheral nervous system neoplasm	1.22e-05	0.00051	CbGpPWpGaD
Trabectedin—SRC—Axon guidance—NRAS—peripheral nervous system neoplasm	1.21e-05	0.000508	CbGpPWpGaD
Trabectedin—SRC—Membrane Trafficking—AKT1—peripheral nervous system neoplasm	1.2e-05	0.000503	CbGpPWpGaD
Trabectedin—SRC—Focal Adhesion—AKT1—peripheral nervous system neoplasm	1.2e-05	0.000503	CbGpPWpGaD
Trabectedin—SRC—Integrated Pancreatic Cancer Pathway—AKT1—peripheral nervous system neoplasm	1.2e-05	0.000501	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—COX2—peripheral nervous system neoplasm	1.17e-05	0.000491	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—GNS—peripheral nervous system neoplasm	1.17e-05	0.000489	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—GNS—peripheral nervous system neoplasm	1.16e-05	0.000485	CbGpPWpGaD
Trabectedin—SRC—Developmental Biology—ERBB2—peripheral nervous system neoplasm	1.14e-05	0.000476	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—BCHE—peripheral nervous system neoplasm	1.13e-05	0.000473	CbGpPWpGaD
Trabectedin—SRC—NGF signalling via TRKA from the plasma membrane—AKT1—peripheral nervous system neoplasm	1.13e-05	0.000471	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—NME1—peripheral nervous system neoplasm	1.12e-05	0.000469	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—NME1—peripheral nervous system neoplasm	1.11e-05	0.000465	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—COX2—peripheral nervous system neoplasm	1.08e-05	0.000452	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.08e-05	0.000451	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—COX2—peripheral nervous system neoplasm	1.07e-05	0.000448	CbGpPWpGaD
Trabectedin—SRC—Platelet activation, signaling and aggregation—AKT1—peripheral nervous system neoplasm	1.06e-05	0.000446	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—TH—peripheral nervous system neoplasm	1.06e-05	0.000444	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.06e-05	0.000443	CbGpPWpGaD
Trabectedin—SRC—Immune System—HGF—peripheral nervous system neoplasm	1.02e-05	0.000425	CbGpPWpGaD
Trabectedin—SRC—Innate Immune System—ERBB2—peripheral nervous system neoplasm	1.01e-05	0.000421	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—ENO2—peripheral nervous system neoplasm	9.98e-06	0.000418	CbGpPWpGaD
Trabectedin—SRC—Signaling by NGF—HRAS—peripheral nervous system neoplasm	9.81e-06	0.000411	CbGpPWpGaD
Trabectedin—SRC—Adaptive Immune System—ERBB2—peripheral nervous system neoplasm	9.65e-06	0.000404	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	9.21e-06	0.000386	CbGpPWpGaD
Trabectedin—SRC—Axon guidance—HRAS—peripheral nervous system neoplasm	8.88e-06	0.000372	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—GNAS—peripheral nervous system neoplasm	8.66e-06	0.000363	CbGpPWpGaD
Trabectedin—SRC—Signaling by NGF—AKT1—peripheral nervous system neoplasm	8.66e-06	0.000362	CbGpPWpGaD
Trabectedin—SRC—Developmental Biology—NRAS—peripheral nervous system neoplasm	8.66e-06	0.000362	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—ABCB1—peripheral nervous system neoplasm	8.5e-06	0.000356	CbGpPWpGaD
Trabectedin—SRC—Hemostasis—NRAS—peripheral nervous system neoplasm	8.49e-06	0.000356	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—BCHE—peripheral nervous system neoplasm	8.44e-06	0.000353	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—SLC2A1—peripheral nervous system neoplasm	8.05e-06	0.000337	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—TH—peripheral nervous system neoplasm	7.93e-06	0.000332	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—KNG1—peripheral nervous system neoplasm	7.88e-06	0.00033	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—ENO2—peripheral nervous system neoplasm	7.7e-06	0.000322	CbGpPWpGaD
Trabectedin—SRC—Innate Immune System—NRAS—peripheral nervous system neoplasm	7.65e-06	0.00032	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—GNS—peripheral nervous system neoplasm	7.64e-06	0.00032	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	7.51e-06	0.000314	CbGpPWpGaD
Trabectedin—SRC—Immune System—PTPN11—peripheral nervous system neoplasm	7.41e-06	0.00031	CbGpPWpGaD
Trabectedin—SRC—Adaptive Immune System—NRAS—peripheral nervous system neoplasm	7.34e-06	0.000307	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—NME1—peripheral nervous system neoplasm	7.33e-06	0.000307	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—ENO2—peripheral nervous system neoplasm	7.08e-06	0.000297	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—COX2—peripheral nervous system neoplasm	7.06e-06	0.000295	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—ENO2—peripheral nervous system neoplasm	7.02e-06	0.000294	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—GNAS—peripheral nervous system neoplasm	6.89e-06	0.000288	CbGpPWpGaD
Trabectedin—SRC—Disease—PTPN11—peripheral nervous system neoplasm	6.84e-06	0.000286	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—BCHE—peripheral nervous system neoplasm	6.51e-06	0.000272	CbGpPWpGaD
Trabectedin—SRC—Hemostasis—TP53—peripheral nervous system neoplasm	6.5e-06	0.000272	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—GNAS—peripheral nervous system neoplasm	6.47e-06	0.000271	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—ABCB1—peripheral nervous system neoplasm	6.35e-06	0.000266	CbGpPWpGaD
Trabectedin—SRC—Developmental Biology—HRAS—peripheral nervous system neoplasm	6.33e-06	0.000265	CbGpPWpGaD
Trabectedin—SRC—Hemostasis—HRAS—peripheral nervous system neoplasm	6.21e-06	0.00026	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—SLC2A1—peripheral nervous system neoplasm	6.21e-06	0.00026	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—TH—peripheral nervous system neoplasm	6.12e-06	0.000256	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—BCHE—peripheral nervous system neoplasm	5.99e-06	0.000251	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—BCHE—peripheral nervous system neoplasm	5.93e-06	0.000248	CbGpPWpGaD
Trabectedin—SRC—Immune System—ERBB2—peripheral nervous system neoplasm	5.85e-06	0.000245	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—SLC2A1—peripheral nervous system neoplasm	5.71e-06	0.000239	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—SLC2A1—peripheral nervous system neoplasm	5.66e-06	0.000237	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—TH—peripheral nervous system neoplasm	5.63e-06	0.000236	CbGpPWpGaD
Trabectedin—SRC—Innate Immune System—HRAS—peripheral nervous system neoplasm	5.59e-06	0.000234	CbGpPWpGaD
Trabectedin—SRC—Developmental Biology—AKT1—peripheral nervous system neoplasm	5.59e-06	0.000234	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—TH—peripheral nervous system neoplasm	5.58e-06	0.000234	CbGpPWpGaD
Trabectedin—SRC—Hemostasis—AKT1—peripheral nervous system neoplasm	5.49e-06	0.00023	CbGpPWpGaD
Trabectedin—SRC—Disease—ERBB2—peripheral nervous system neoplasm	5.4e-06	0.000226	CbGpPWpGaD
Trabectedin—SRC—Adaptive Immune System—HRAS—peripheral nervous system neoplasm	5.37e-06	0.000225	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—GNAS—peripheral nervous system neoplasm	5e-06	0.000209	CbGpPWpGaD
Trabectedin—SRC—Innate Immune System—AKT1—peripheral nervous system neoplasm	4.94e-06	0.000207	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—ABCB1—peripheral nervous system neoplasm	4.9e-06	0.000205	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	4.79e-06	0.0002	CbGpPWpGaD
Trabectedin—SRC—Adaptive Immune System—AKT1—peripheral nervous system neoplasm	4.74e-06	0.000199	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—ENO2—peripheral nervous system neoplasm	4.63e-06	0.000194	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—GNAS—peripheral nervous system neoplasm	4.59e-06	0.000192	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—GNAS—peripheral nervous system neoplasm	4.55e-06	0.000191	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—ABCB1—peripheral nervous system neoplasm	4.51e-06	0.000189	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—ABCB1—peripheral nervous system neoplasm	4.47e-06	0.000187	CbGpPWpGaD
Trabectedin—SRC—Immune System—NRAS—peripheral nervous system neoplasm	4.45e-06	0.000186	CbGpPWpGaD
Trabectedin—SRC—Disease—NRAS—peripheral nervous system neoplasm	4.11e-06	0.000172	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—BCHE—peripheral nervous system neoplasm	3.91e-06	0.000164	CbGpPWpGaD
Trabectedin—SRC—Disease—MYC—peripheral nervous system neoplasm	3.83e-06	0.00016	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	3.78e-06	0.000158	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—SLC2A1—peripheral nervous system neoplasm	3.73e-06	0.000156	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—TH—peripheral nervous system neoplasm	3.68e-06	0.000154	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—CASP3—peripheral nervous system neoplasm	3.44e-06	0.000144	CbGpPWpGaD
Trabectedin—SRC—Immune System—HRAS—peripheral nervous system neoplasm	3.26e-06	0.000136	CbGpPWpGaD
Trabectedin—SRC—Disease—HRAS—peripheral nervous system neoplasm	3.01e-06	0.000126	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—GNAS—peripheral nervous system neoplasm	3e-06	0.000126	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—ABCB1—peripheral nervous system neoplasm	2.95e-06	0.000123	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—NRAS—peripheral nervous system neoplasm	2.88e-06	0.000121	CbGpPWpGaD
Trabectedin—SRC—Immune System—AKT1—peripheral nervous system neoplasm	2.88e-06	0.00012	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—MYC—peripheral nervous system neoplasm	2.68e-06	0.000112	CbGpPWpGaD
Trabectedin—SRC—Disease—AKT1—peripheral nervous system neoplasm	2.66e-06	0.000111	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—AKT1—peripheral nervous system neoplasm	2.34e-06	9.79e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—TP53—peripheral nervous system neoplasm	2.2e-06	9.22e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—HRAS—peripheral nervous system neoplasm	2.11e-06	8.82e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—AKT1—peripheral nervous system neoplasm	1.86e-06	7.79e-05	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—AKT1—peripheral nervous system neoplasm	1.75e-06	7.32e-05	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—AKT1—peripheral nervous system neoplasm	1.35e-06	5.64e-05	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—AKT1—peripheral nervous system neoplasm	1.24e-06	5.19e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—AKT1—peripheral nervous system neoplasm	1.23e-06	5.15e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—AKT1—peripheral nervous system neoplasm	8.11e-07	3.39e-05	CbGpPWpGaD
